<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 103 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page102.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=103">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 103 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 103</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=103"><img src="../thumb/103.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>72 / 2020-04                                                        Musculo-Skeletal Agents - 4.1.1
   Special precautions: Hypertens. &/ HF hist, cardiocirculat.fail.,   not recomm., monit. long-term.ther., concom.methotrex., concom.   lev of diabet.on oral agents, methotrexate toxic., concom.ciclospor./
   arter.hypertens., reduc.ren./liv. funct., GI bleed./perforat.risk high.  hydantoin/ sulphonamide/sulphonylureas for poss. dos. adjustm.  NSAID, pass.into breast milk, poss.fem.fertil.impairm., avoid concom.
   with incr.dos.in pts.with ulc. hist./elderly, asthma, bronchosp., bleed.   Drug interactions: Interact.report.with some ARV’s with atazanavir   system.NSAID’s incl.cyclo-oxygenase-2 select.inhibit.as synergist.
   disords., CV dis., CHF, cirrhos., diuret.-induc. vol.deplet./ren.insuff.  & nelfinavir ser.lev.decr.  benef. absen. & addit.undesir.effs.poss., asthma exacerbat. react.
   req.loc.synthes.of vasodilat. prostagland.to maint.ren.perfus., con-  & incr. saquinavir.ser.lev., decr.max.inhibit.of platelet aggregat.with   more freq.in asthmat./season. allerg.rhinit./COPD/chron. RTI esp.
   com.meds. inhibit. platel.aggregat., caref.cons.in case of signif. GI   clopidogrel, natriuret.eff.of furosemide & thiazide reduc., bleed.risk.  if link.to allerg. rhinit.-like sympts.& allerg.pts., GI dis./hist. suggest.
   events risk fact., avoid in pts.old.than 80 yrs., incr.GI compl.risk with   potent. assoc. with SSRI’s, antihypertens.effs.of ACE-inhibit. /beta-  ulcerat./bleed./perforat., ulcerat.colit./ Crohn’s dis., bleed.risk incr.
   concom. SSRI’s/ corticoster./antiplatel.agents, cons.eg.misoprodol/   block.poss.dimin., incr.Li plasma lev., poss. enhanc.toxic.of metho-  with concom. corticoster./ anticoags./anti-platelet agents & SSRI’s,
   proton pump inhibits.for at-risk pts., alert dr.if any new/unus.abdom.  trex., incr.nephrotox. risk with cyclospor., probenec.signific.incr.   imp.hepat./card./ren.funct., discont.ther.in case of persist./worsen.
   sympt.& ther.to be discont.if GI compl. susp., hiat.hern./GERD hist.,   naprox. half-life, poss.incr./decr.absorpt.of drugs whose absorpt. is   LFT/liv.dis.S&S devel., hypertens.hist., extra cellul.vol.deplet., reg.bld.
         st
   discont.ther.at 1  sign of skin rash/hypersens./mucos.les., concom.   influenc.by gastric acid., ketoconazole & itraconazole absorpt.decr.,   count monit.esp.in pres.of haemostas.defect., Amps: parent.use esp.
   Li/ high.prot-bound meds., poss. methotrex. toxic., est.ischaem.heart   cholestyram.delay naprox. absorpt., poss.incr.plasma conc.of meds.   in bronch.asthma pts.as sympt. poss. exacerbat.
   dis./ cerebrovasc. &/periph.arter.dis., longt.ther.in pts. with CV events   metabol. by CYP2C19 enzyme, diazepam clear. decr., incr.phenytoin   Drug interactions: Poss.rais.Li & digox.plasma conc., antihyper-
                                                                                   +
   risk, incr.arter.thrombot.events risk, no re-challenge in case of tox.  plasma conc., elev.INR with warfar.  tens.eff.of diuret.& antihypertens. agents decr., K -spar.drugs poss.
   epiderm. necrolys./ Stev.Johns.syndr., discont.if vis.chang./abnorm.  incr.ser.K  lev., corticoster./ other NSAID’s & SSRI’s may incr. undes.
                                                                  +
   LFT persist or wors., cons.withdr.ther.in women hav. diffic. conceiv./  VOLTAREN, Novartis [P/S]  GI effs., bioavail.reduc.by acetylsal.acid & vice versa, incr.haemorrh.
                                Diclofenac sodium.
   undergo.fertil.investig., collag.dis., concom.warfar.      risk with anticoags., methotrex.bld.conc.poss.rise, incr.cyclosporin.
   Drug interactions: Anticoag.eff.enhanc., incr. bleed. risk with SS-  Indications: Inflam.& degen.forms of rheumat., painf.musc.skelet.  nephrotoxic., poss.convuls.with quinolon.
                                condit., non-articul. rheumat., ac.gout attacks, mild to mod.painf.
   RI’s/antiplatel.agents, incr.S/E with concom. NSAID’s, incr.nephro-
   toxic.risk with ciclospor./ tacrolimus, incr.absorpt.with cimetidine,   post-op.& post-traum.inflam.& swell., pain follow.dent. surg., prim.  XEFO, Takeda [P/S]
                                dysmenorrh.
   Li conc.incr., reduc.methotrex.excret., incr.convuls.risk with quino-  Lornoxicam.
   lon., poss.interfer.with mifepristone-mediat.pregn.terminat., effs.of   (S3) TABS, [P/S] G/3.1/83, K/3.1/253.  Indications Short term.treatm.of mild to mod. pain assoc.with ex-
                                778206-018: 25 mg, 50, R82,38
   other prot.-bound poss.displac., antihypertens. eff.of antihypertens.  tra artic.inflamm., symptomat. treatm.of pain & inflammat.in osteo-
   decr., interfer.with diurets.natriuret. act., incr.plasma glycoside.lev.  778222-013: GT 50 mg, 20, R67,04  arthrit.& rheumat.arthrit.
                                Dosage: Indiv.to low.effect.dos.for short.poss. durat. Do not div./
                                                              (S3) TABS, [P/S] 33/3.1/0247, 0248.
   VELTEX, AI Pharm Ltd [P/S] &  chew. Take on empty stomach for ac.pain.relief. Admin.in 2-3 div.dos.  860654-001: 4 mg, 20, R106,36
   Diclofenac.sod.              Adults: Recomm.init.dly.dos: 100-150 mg dly. Mild. cases & long   860662-004: 8 mg, 20, R151,70
   Indications Rheumat./osteo-& spondyl.arthrit., ankylos. spondy-  term ther: 75-100 mg dly. Max: 150 mg dly.  860662-012: 8 mg, 100, R758,44
   lit., painf.musculoskelet.condit., non-articul. rheumatism, ac.gout   Prim.dysmenorrh: Init.50-100 mg dly.incr.over sev.menstr.cycl.to   Dosage: Admin.bef.meals. Individualise.
   attacks, painf. post-op.& post-traumat.inflammat.& swell., dent.   max.200 mg/day if necess.  Pain: 8-16 mg/day in 2-3 div.dos. Max.tot.dly. dos.16 mg.
   surg. pain, prim.dysmenorrh.  Juven.rheumat.arthrit: Dly.dos.may be incr.to max.3 mg/kg dly.  (S3) RAPID TABS, [P/S] 44/3.1/0331
   (S3) CR CAPS, 27/3.1/321, W/3.1/329  in div.dos.           Indications Short term.treatm.of mild to mod. pain where intra-
   793663-017: 75 mg, 6, R31,14  (S3) 75 TABS, [P/S] Y/3.1/346  musc.use inappropr.(not exceed 72 hrs.)
   793663-016: 75 mg, 30, R155,80  789240-009: 75 mg, 30, R238,32  717776-002: 8 mg, 20, R164,73
   787272-019: 100 mg, 30, R303,34  (S3) SIMPLE REGIMEN 100, [P/S] M/3.1/63.  Dosage: Admin.bef.meals with suffic.water. Individualise.
   Adults: Swall.whole. Do not chew. Init.dly.dos: 100-150 mg.  778230-015: 100 mg, 30, R250,77  Admin.in 8 mg dos.with dly.dos.not exceed.16 mg. In some pts.a
                                                                         st
   Mild cases & as maint.ther: 75-100 mg/day. Max.dly.dos: 150 mg   Dosage: Admin.pref.at mealt.in even. Do not break/ chew. Init.  furth.8 mg giv.within the 1  24 hrs. may be need.
   admin.as 2-3 div.dos.        dly.dos: 100-150 mg dly. Mild. cas.& long term ther: 75 mg dly.  (S3) INJ, 33/3.1/0249.
   Analges: Indiv. Dos: 75-150 mg to be start. with first sympt.& con-  usual.suffic.  Indications: Short term treatm.of mild to mod. pain when oral
   tin.for a few days depend.on sev. Pref.to be giv.in the even.should   (S3) DROPS, [P/S] Y/3.1/347.  admin.inappropr.
   sympt.be most evid. dur. night/early morn. Childr.able to swall.   Diclofen.resinate equiv.to diclofenac sodium 15 mg/ml, 1 drp=0,5 mg   860670-007: 8 mg/vial, 5 vials, R198,24
   caps: 1-3 mg/kg bm recomm.   (1 ml=30 drps.)               Dosage: Admin.IV/IM
   Contraindications: Asthma pts.where attacks of asthma, urticar./  791253-007: 20 ml, R107,69  Admin.in 8 mg dos. Dly.dos.not exceed.16 mg. A further 8 mg within
                                                               st
   ac.rhinit.are precipitat.by acetylsalicyl. acid/medic.with prostagland.   Dosage: Indiv. Admin.low.effect.dos.for short. poss.per. Adults:   1  24 hrs.could be need.
   synthetase inhibit. activ., porphyr., not recomm.in childr.und.2 yrs./  Init: 100-150 mg/day. Mild.cas./ longt.ther: 75-100 mg/day. Dly.max:   Contraindications: Prev.hypersens.reacts.to other NSAID meds.
   unab.to swall.caps.          150 mg div.in 2-3 dos. Childr. 2 yrs.& over /adolesc: 0,5-2 mg/kg   incl.acetyl.salicyl.acid., GI bleed./perforat.relat.to prev.NSAID ther.,
   Side effects: GI disturbs.incl.bleed., pept.ulc.., CNS eff., headache,   bm dly.in 2-3 div.dos.depend.on sever.of disord.   cerebrovasc. bleed., bleed.& coagulat.disords., act. pept. ulcerat./
   dizzin., drowsin., blurr.vis., tinnit., oed., skin reacts., abnorm.LFT, imp.  Juven.rheum.arthrit: Dly.max.dos.3 mg/kg/day in div.dos.  hist. of recurr.pept.ulcerat., sev.liv./ ren. impairm., thrombocytopen.,
   ren. funct., bld.dyscras., ac.allerg./hypersens.reacts., jaund., hepatit.,   Prim.dysmenorrh: Dly.dos.adjust.indiv.usual.50-150 mg. Init. 50-  sev./ uncontr.CF, elderly (&gt;65 yrs.), pregn.& lactat., childr.und.18 yrs.,
   ren.fail., nephrot. syndr., min.hear. disords., palpits.  100 mg init.& incr.over sever. menstr. cycles up to max.of 200 mg/day.  Tabs & rapid tabs.also: weigh. &lt; 50 kg & for ac. surg., Inj & rapid
   Warnings and special precautions: Asthma, bronchosp., bleed.  (S3) INJ, [P/S] H/3.1/34. 75 mg/3 ml.  tabs. also: hypovolaem./dehydrat.
   disords., pept.ulc./hist.thereof, CV dis., GI sympts., monit.imp.ren./  Indications: IMI: Init.ther.for inflam.& degen. rheumat. dis., mild to   Side effects: Pharyngit., loc.reacts., CNS effs., oed., allerg.reacts.,
   hepat./card. funct., discont. if pept.ulcerat./GI bleed.occurs., may   mod.painf.inflam.of non-rheumat. condit.  conjunctiv., vis.disords., incr. sweat., GI disturbs.incl.pept.ulcerat.with/
   mask S&S of infects., not to be giv.in pregn.& lactat.  IV infus: Treatm./prev.of post-op mild to mod.pain of inflamm.orig.  without bleed., haemorrhoid./rect.bleed., bld.dyscras., prolong. bleed.
   Interactions: Admin.with care with concom. coumar. anticoag.  in absenc.of infect.  time, ecchymos., hypersens., weight changes, musc.-skelet.disords.,
   ther., ser.interacts.with high dos. methotrex., incr.Li & digox.plasma   778249-018: 5 x 3 ml amps., R80,07  migraine, paraesthes., taste pervers., tinnit., trem., resp.& skin disor-
   conc., poss. NSAID cross-sens., ac.allerg.reacts esp.in pts.who prev.   Dosage: IM Adults: 1 amp/day deep intra-gluteally. Sev.cases:   ds.incl.Stev.John & tox.epiderm. necrolys., micturit.disords., palpitat.,
   exhib.allerg.reacts.to these compnds., aspir. decr. plasma conc., glu-  2 amps./day separt.by few hr. inter.OR combin.1 amp.with oral ther.  tachycard., CF, abnorm.hepat.funct., BP chang.
   cocortic./other NSAIDs may aggrav.GI side-eff., reduc. dos.in elderly.  to max. dly.dos.of 150 mg.  Special precautions: Discont.ther.with appropr. therapeut.act.if GI
   See also MDR page 119.       Intraven.infus: Dil 1 amp with 100-500 ml NaCl 0,9% or 5%gluc.sol.  ulcerat./bleed. develops, prev.cerebrovasc.haemorrh., SLE, ulc.colit.,
                                Mod.to sev.post-op pain: 1 amp.to be infus. continuous. over
   VIMOVO, AstraZeneca [P/S]    30mins.-2 hrs. May be repeat.if necess. Max.dos: 150 mg/24 hrs.  Crohn’s dis., porphyr., haematopoiet. disords., reduc.card.funct., hypertens.,
                                                              hepat.dis., coagulat.disords., treatm.long.than 3 mnths., elderly (&gt;65yrs.)
   Naproxen 500 mg, esomeprazole 20 mg  Post-op prophylax: Load.dos: 25 -50 mg infus. aft. surg. over   & weigh.&lt;50 kg & for ac.surg., imp. ren.funct., monit.ren.funct.in pts.for
   Indications: Rheumat.arthrit., osteoarthrit., ankylos. spondylit.in pts.  15 mins.-1 hr.follow.by contin.infus. of approx.5 mg/hr. Max.dos:   maj. surg./comprom.ren.funct./CF/concom.diuret.or nephrotox.meds.
   need.proton-pump inhibit.to reduc.NSAID assoc.gastr./duod.ulc.risk  150 mg dly. Do not admin. for more than 2 days. Treatm.may be con-  Drug interactions: Poss.prolong.bleed.time with concom.anticoag./
   (S4) TABS, 45/3.1/0179       tin. with tabs./supp.if necess.  platelet.aggregat.inhibit., poss. incr.hypoglcaem.eff.with sulphonylu-
   718724-001: 30, R145,02      (S3) SUPP, [P/S] R/3.1/224, L/3.1/126.  reas., incr.risk of S/E with other NSAID & asprin., decr.effic.of loop diu-
   718724-002: 60, R290,02      Indications: Painf.post-op.& post-traum.inflam.& swell.  ret., decr.eff.of ACE inhibit./ ARB’s & risk of ac.ren.insuff., incr.Li peak
   Dosage: Admin.30 mins.prior to food. Swallow whole  780863-003: 25 mg, 5, R83,23  conc., incr.ser.conc.of high dos.methotrexate., high. plasma conc.with
   Adults: 1 tab.2xdly.         778214-001: 100 mg, 5, R88,56  cimetidine, decr.digox.ren. clear., incr.ren.toxic.with cyclosporin, incr.
   Contraindications: Asthma/urticar.or allerg. type reacts.to NSAID’s/  Dosage: Never div.suppos. Childr. 2 yrs.or old: 2-3 mg/kg bm dly.  risk of GI ulcerat./bleed.with corticoster., anticoags. effs. enhanc., anti-
   aspirin, pregn., lactat., sev. hepat.impairm., concom.atazanavir & nel-  in 2-3 div.doses. Adults: 100 mg dly. When used to supplem.tabs.  platelet agents & SSRI’s incr. GI bleed.risk, CYP2C9 induc.& inhibit.
   finavir not recomm., not recomm.in childr.  admin.1 supp.at bedt.up to max.of 150 mg dly.
   Side effects: GI disturbs. & bleed.incl.ulcerat.or perforat. poss.fatal   Contraindications: Gastr./intest.ulc./bleed./ perforat., asthmat.pts.  XYCAM, (Aspen Pharmacare: Pharma) Pharmacare [P/S]
   without warn.signs,, ser.skin reacts. incl.Stev.John.syndr./exfoliat.  where asthma attacks/ urticar./ ac.rhinit.precpit.by acetylsalicyl. acid/   Piroxicam.
   dermatit & tox. epiderm.necrolys., hypersens.reacts.incl. anaphylact.   other NSAID’s, pregn.& lactat., porphyr., childr. und. 2 yrs, hepat./ren./  Indications: Rheum.& osteo-arthrit., ankylos. spondyl.,ac.musculo-
   reacts., upper abdom.pain, dizzin., periph.oed., abnorm.LFT, palpitat.,   card.fail., Amps.also: IV use in childr., absolut.C/I in imp.ren.funct. &/   skelet.disords., ac.gout.
   dysrhythm., CHF, MI, tachycard., bld dyscras., CNS effs.incl. cognit.   shock, sens.to sod.metabisulph, childr.und.14 yrs.for 50/75 & 100 mg   (S3) CAPS, [P/S] V/3.1/250.
   dysfunct./coma & convuls., blurr.vis.& other ocul.reacts., tinnit., hear.  tabs/amps.&100 mg suppos., IV bolus inj./mix.with other inj.sols.   797030-018: 20 mg, 30, R34,59
   disturbs., dyspn., asthma, bronchosp., eosinophil.pneumonit., pneu-  Supp.also: proctit, GT Tabs also: lact.intol.  797030-026: 20 mg, 500, R576,14
   mon., pulm.oed., resp.depress., pancreatit., exacerbat. of inflamm.  Side effects: Amps.& supp: loc.reacts., oed., bld. dyscras., hypers-  (S3) DISPERS.TABS, [P/S] Y/3.1/227.
   bowel dis., ren.& urin. disords., prurit., ecchymos., purpura, skin   ens.reacts.incl.angioneurot. oed.& anaphylax., psych./CNS disords.,   797049-002: 20 mg, 30, R42,76
   rashes, alopec., urticar., photosens., musc.weakn., myalg., hyper-/   headache, dizzin., paraesthes., convuls., trem., asept.meningit., CVA,   Dosage: Admin.low.effect.dos.for shortest durat.of treatm.
   hypoglycaem., hyperkalaem., hyperuricaem., hyponatraem., weight   taste/vis.disturbs., vertigo, tinnit., imp.hear., palpitat., chest pain, CF,   Rheumat./osteo-arthrit.& ankylos.spondylit.: 20 mg dly in sngl./
   changes, hyper-/ hypotens., vasculit., fatig., oed., sweat., thirst, mal-  MI, hypertens., vasculit., asthma, pneumonit., GI disturbs.incl.bleed./   div. dos. Range 10-30 mg dly.
   aise, pyrex., cholestas., hepatit., liv.fail., psych. disords. incl.agitat.&   ulcerat./ perforat. & pancreatit., stomatit., glossit., colit./ulcerat.colit./  Ac.musc.-skelet.disords: 7-14 days treatm. Init. 40 mg dly.in sngl./
   hallucinat., gynaecomast.    Crohn’s exacerbat., hepatit., jaund., liv.disord., skin reacts.somet.fatal.  div.dos.x2 days, then 20 mg dly.
   Special precautions: Elderly at incr.risk of NSAID advers.reacts.,   incl. exfoliat.dermatit./Stev.-Johns.& tox. piderm. necrolys., alopec.,   Ac.gout: 40 mg x5-7 days. Not for long-term managem.
   formulat.to decr.GI S/E but ulcerat. & complicat.still poss., GI bleed.  photosens., ac.ren.fail., urin. abnormalit., hypo-/hyperglycaem., Supp:   Contraindications: Hepat.dysfunct., childr.und. 12yrs., aspir./NSAID
   risk high. with incr.dos./ulc.and complicat.hist.& elderly, concom.   loc.irrit.& syst.S/E, exacerbat. haemorrh., Amps: loc.pain & indurat.,   cross-sens., concom. anticoags., pept.ulcerat., GI bleed.hist., ac. por-
   meds.that incr.ulcerat./bleed.risk, discont. if bleed./ulcerat.occur,   abscess, loc.necros.esp. in elderly & diabet.  phyr., heart fail., pregn.& lactat.
   GI dis.hist., excl.poss. malign., uncontrol.hypertens., CHF , ischaem.  Warnings and special precautions: Monit. concom.Li/digox./an-  Side effects: GI disturbs.incl.GI haemorrh./ perforat.& ulcerat., hy-
   heart dis., periph.arter.dis., cererovasc.dis., CV event risk fact., imp.  ticoags./ K -spar.drugs/ antihypertens., poss.masks S&S of infect.,   persens.reacts., hypo & hyperglycaem., psych.disords., skin rash incl.
                                     +
   ren.funct., hypovolaem., liv.dysfunct., salt deplet. concom.diuret.  discont. if GI bleed./ ulcerat. occurs/1  appear.of skin rash/ mucos.  exfoliat. dermat., Stev.Johns & tox.epiderm. necrolys., photosens.re-
                                                st
   ther., coagulat.disords., ther. interfer.with haemostas., bleed.risk,   les./other hypersens.signs, elderly esp. frail/ low bm, reg.BP monit.  acts., bld.dyscras., CNS effs., blurr.vis., eye irrit., tinnit., HF, hypertens.,
   decr. platelet aggregat.& prolong.bleed.time, pre-exist. asthma,   in hypertens.pts., adeq. hydrat., ren.funct.monit.init.with diurets./ACE   oed., changes in liv.funct., prurit., interstit.nephrit., ren.fail., decr.platel.
   signs of inflammat.reduc., concom.non-aspir. NSAID’s & clopidogrel   inhibits. & per.thereaft.due to incr.nephrotoxic. risk, monit.bld.gluc.  aggregat.& prolong.bleed. time.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page102.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page98.html">98</a>&nbsp;&nbsp;&nbsp;<a href="page99.html">99</a>&nbsp;&nbsp;&nbsp;<a href="page100.html">100</a>&nbsp;&nbsp;&nbsp;<a href="page101.html">101</a>&nbsp;&nbsp;&nbsp;<a href="page102.html">102</a>&nbsp;&nbsp;&nbsp;<a href="page103.html">103</a>&nbsp;&nbsp;&nbsp;<a href="page104.html">104</a>&nbsp;&nbsp;&nbsp;<a href="page105.html">105</a>&nbsp;&nbsp;&nbsp;<a href="page106.html">106</a>&nbsp;&nbsp;&nbsp;<a href="page107.html">107</a>&nbsp;&nbsp;&nbsp;<a href="page108.html">108</a>
             </td>
             <td width="35%"><a href="page104.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page104.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
